Piramal Pharma Solutions, a CDMO, part of Piramal Pharma Ltd., opened its expanded antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. The expansion further enhances the site’s capacity by approximately seventy to eighty percent, enabling scale-up of commercial ADC manufacturing batches. The capacity expansion features two new ADC manufacturing suites specifically designed to complement the existing three. The £45 million investment was financed by a combination of ...